Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis

BACKGROUND: Dabigatran etexilate, a new thrombin inhibitor, has been shown to be comparable to warfarin in patients with atrial fibrillation (AF). However, there is a limited body of evidence on the efficacy and safety of using dabigatran among patients undergoing AF catheter ablation. OBJECTIVE: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Providência, Rui, Albenque, Jean-Paul, Combes, Stephane, Bouzeman, Abdeslam, Casteigt, Benjamin, Combes, Nicolas, Narayanan, Kumar, Marijon, Eloi, Boveda, Serge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Arrhythmias and Sudden Death
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913219/
https://www.ncbi.nlm.nih.gov/pubmed/23878175
http://dx.doi.org/10.1136/heartjnl-2013-304386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913219/
https://www.ncbi.nlm.nih.gov/pubmed/23878175
http://dx.doi.org/10.1136/heartjnl-2013-304386

Ejemplares similares